SynthesisCPT: pharmacometrics & systems pharmacology2021

PK/PD modeling analysis for dosing regimen selection of isatuximab as single agent and in combination therapy in patients with multiple myeloma.

Kimiko Koiwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.